RS001

· Guangdong Ruishun Biotech Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RS001, covering 2025-03-25 to 2025-03-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Clinical Trial of RS001 in Patients with Relapsed/Refractory B-Cell Malignancies [Phase 1]